Name | Number of supported studies | Average coverage | |
---|---|---|---|
vein endothelial cell | 3 studies | 58% ± 20% |
Insufficient scRNA-seq data for expression of MADCAM1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 247.19 | 2628 / 2642 | 84% | 2.97 | 590 / 705 |
pancreas | 91% | 133.24 | 297 / 328 | 72% | 5.80 | 129 / 178 |
stomach | 94% | 164.30 | 336 / 359 | 52% | 2.17 | 150 / 286 |
adrenal gland | 86% | 58.39 | 223 / 258 | 59% | 2.27 | 135 / 230 |
intestine | 97% | 466.72 | 938 / 966 | 48% | 1.67 | 251 / 527 |
prostate | 91% | 69.61 | 224 / 245 | 35% | 0.70 | 178 / 502 |
thymus | 98% | 169.72 | 637 / 653 | 24% | 0.61 | 148 / 605 |
bladder | 90% | 55.29 | 19 / 21 | 25% | 0.62 | 126 / 504 |
esophagus | 78% | 69.73 | 1120 / 1445 | 25% | 0.74 | 46 / 183 |
breast | 86% | 87.32 | 397 / 459 | 14% | 0.27 | 153 / 1118 |
spleen | 100% | 428.80 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.55 | 1 / 1 |
skin | 73% | 41.04 | 1322 / 1809 | 26% | 0.46 | 122 / 472 |
ovary | 79% | 51.19 | 143 / 180 | 15% | 0.25 | 63 / 430 |
liver | 68% | 40.22 | 153 / 226 | 24% | 0.57 | 97 / 406 |
uterus | 77% | 48.77 | 131 / 170 | 13% | 0.30 | 60 / 459 |
kidney | 72% | 41.47 | 64 / 89 | 18% | 0.33 | 159 / 901 |
lung | 61% | 33.70 | 354 / 578 | 22% | 0.79 | 252 / 1155 |
adipose | 78% | 61.37 | 937 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 58% | 40.01 | 537 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 50% | 27.29 | 664 / 1335 | 0% | 0 | 0 / 0 |
muscle | 47% | 22.25 | 378 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 45% | 5.43 | 13 / 29 |
heart | 32% | 13.58 | 279 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 9% | 0.19 | 7 / 80 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.06 | 2 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007165 | Biological process | signal transduction |
GO_0006955 | Biological process | immune response |
GO_0050901 | Biological process | leukocyte tethering or rolling |
GO_0007229 | Biological process | integrin-mediated signaling pathway |
GO_0007155 | Biological process | cell adhesion |
GO_0034113 | Biological process | heterotypic cell-cell adhesion |
GO_2000403 | Biological process | positive regulation of lymphocyte migration |
GO_0043113 | Biological process | receptor clustering |
GO_0007160 | Biological process | cell-matrix adhesion |
GO_0002687 | Biological process | positive regulation of leukocyte migration |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0098640 | Molecular function | integrin binding involved in cell-matrix adhesion |
Gene name | MADCAM1 |
Protein name | Mucosal addressin cell adhesion molecule 1 (MAdCAM-1) (hMAdCAM-1) MADCAM1 protein Mucosal vascular addressin cell adhesion molecule 1 Mucosal vascular addressin cell adhesion molecule 1 transcript variant 1 |
Synonyms | |
Description | FUNCTION: Cell adhesion leukocyte receptor expressed by mucosal venules, helps to direct lymphocyte traffic into mucosal tissues including the Peyer patches and the intestinal lamina propria. It can bind both integrin alpha-4/beta-7 and L-selectin, regulating both the passage and retention of leukocytes. Isoform 2, lacking the mucin-like domain, may be specialized in supporting integrin alpha-4/beta-7-dependent adhesion strengthening, independent of L-selectin binding. |
Accessions | ENST00000382683.8 [Q13477-4] U3KQ59 Q13477 ENST00000587541.5 ENST00000346144.8 [Q13477-3] B9EGE2 ENST00000215637.8 [Q13477-1] Q4PKD0 Q5PY60 |